Bills of Congress
H.R.1117 - Responsibility in Drug Advertising Act of 2025 (119th Congress)
H.R.1117, the Responsibility in Drug Advertising Act of 2025, aims to amend the Federal Food, Drug, and Cosmetic Act to restrict direct-to-consumer (DTC) advertising of prescription drugs. The bill proposes a three-year moratorium on DTC advertising for newly approved drugs, …
H.R.1117, the Responsibility in Drug Advertising Act of 2025, aims to amend the Federal Food, Drug, and Cosmetic Act to …